Skip to main content

Contact Adeniyi Olagunju

From: Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial

Contact corresponding author
\